Browsing Category

Top Industry News

7537 posts

Merck & Co. Begins Construction of New $1-Bn Biologics Center of Excellence in Delaware 
By

By
Merck & Co. has started construction of a new $1-billion, 470,000-square-foot biologics Center of Excellence in Wilmington, Delaware.  The center will comprise laboratory, manufacturing and warehouse capabilities to enable the…

Thermo Fisher To Invest $2 Bn in Mfg & R&D in the US   
By

By
Thermo Fisher Scientific has announced plans to invest an additional $2 billion in the US over the next four years. The investment over the next four years includes:  The company…

Sanofi Completes $11.4-Bn Sale of Controlling Stake in Consumer Healthcare Biz Opella 
By

By
Sanofi has completed its sale of a 50% controlling stake in its consumer healthcare business, Opella, to CD&R, an investment firm, for EUR 10 billion ($11.4 billion).  Following closing, CD&R…

Amgen Announces $900-M Facility Expansion in Ohio 
By

By
Amgen has announced a $900-million expansion of its facility in New Albany, Ohio.  Amgen first announced plans to build the Ohio facility in June 2021, and last year (February 2024),…

Supplier News: Lotte Biologics, PCI Pharma, Roquette & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Lotte Biologics, PCI Pharma Services/Ajinomoto Althea, Roquette/IFF Pharma Solutions, Suanfarma, and Olon.    Biologics Manufacturing * Lotte Biologics Begins Ops at ADC Facility Formulation Development/Drug…

Global Briefs: Merck KGaA, Novartis, Lilly & More 
By

By
A roundup of news from Merck KGaA/SpringWorks Therapeutics, Novartis/Regulus Therapeutics, and Eli Lilly and Company/Creyon Bio. Highlights below.   M&A News * Merck KGaA To Acquire SpringWorks Therapeutics for $3.9 Bn* Novartis…

Roche to Invest $50 Bn in US Mfg & R&D Over Five Years 
By

By
Roche has announced that it will invest $50 billion in existing and new research and development (R&D) and manufacturing  facilities in its pharmaceuticals and diagnostics operations in the US in…

Fujifilm, Regeneron in 10-Year, $3-Bn US Mfg Pact 
By

By
Fujifilm Diosynth Biotechnologies, a CDMO of biologics and advanced therapies, has entered a 10-year manufacturing supply agreement, valued at over $3 billion, with Regeneron Pharmaceuticals, a Tarrytown, New York-based bio/pharmaceutical…

PCI Pharma Services To Acquire Fill-Finish CDMO Ajinomoto Althea 
By

By
PCI Pharma Services, a Philadelphia, Pennsylvania-based CDMO, has agreed to acquire the entire equity stake in Ajinomoto Althea, a San Diego, California-based sterile fill–finish CDMO and 100% subsidiary of the…

Supplier News: Phlow, Evotec & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Phlow, Evotec and Eversana.   Chemicals/Chemical API Manufacturing * Phlow Expands Analytical Capabilities, Advances AI in Mfg General * Evotec Provides Update to Strategic Plan * Eversana…